On April 30, 2019 Cambrex Corporation (NYSE: CBM), the leading small molecule company providing drug substance, drug product and analytical services across the entire drug lifecycle, reported that first quarter 2019 financial results will be released on Thursday, May 2, 2019 before the market opens (Press release, Cambrex, APR 30, 2019, View Source [SID1234535466]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

The Company will host a conference call to discuss the financial results.

First Quarter 2019 Earnings Conference Call

When: Thursday, May 2, 2019 at 8:30 a.m. Eastern Time

Dial-in: 1-800-682-0995 for U.S.
1-334-323-0522 for International
Passcode: 2251796

Dial-in Replay: 1-888-203-1112 for U.S.
1-719-457-0820 for International
Passcode: 2251796
Available through Thursday, May 9, 2019

Webcast: www.cambrex.com